| 注册
首页|期刊导航|中国药业|罗哌卡因复合舒芬太尼硬膜外分娩镇痛效果及安全性分析

罗哌卡因复合舒芬太尼硬膜外分娩镇痛效果及安全性分析

姜国玉 何开华

中国药业2017,Vol.26Issue(24):33-35,3.
中国药业2017,Vol.26Issue(24):33-35,3.DOI:10.3969/j.issn.1006-4931.2017.24.011

罗哌卡因复合舒芬太尼硬膜外分娩镇痛效果及安全性分析

Efficacy and Safety of Epidural Labor Analgesia with Ropivacaine Combined with Sufentanil

姜国玉 1何开华2

作者信息

  • 1. 重庆医科大学附属第一医院麻醉科,重庆400016
  • 2. 重庆市人民医院(三院院区)麻醉科,重庆400016
  • 折叠

摘要

Abstract

Objective To investigate the efficacy and safety of epidural labor analgesia with 0.1% ropivacaine combined with sufentanil.Methods Totally 122 primiparas with vaginal delivery vaginal delivery from June 2016 to June 2017 in Chongqing People's Hospital were selected and divided into natural delivery group (the control group) and labor analgesia group (the study group) according to the different methods of labor analgesia.Results There were no significant difference in the duration of labor,Apgar score,modified Bromage score between the two groups(P > 0.05).The rates of lateral episiotomy and cesarean section in the study group were 16.13% and 9.68%,respectively,which were significantly lower than 26.67% and 30.00% in the control group(P < 0.05).The VAS scores of the study group were (3.1 ± 0.6) points for 30 min of analgesia,(2.9 ± 0.3) points for the active period,(1.6± 0.7) points for the second production course,and (1.8 ±0.7) points for the third production process,which were significantly lower than (8.1±0.8) points,(9.2±0.6) points,(7.8±0.6) points,(7.4±0.7) points of the control group(P < 0.05).Conclusion Epidural labor analgesia with 0.1% ropivacaine combined with sufentanil has significant inhibitory effect on labor pain,does not extend the labor process or increase the rate of instrument delivery,at the same time,it can reduce the rate of lateral episiotomy,which is beneficial to the safety of mother and infant.

关键词

罗哌卡因/阴道分娩/硬膜外分娩镇痛/临床疗效/母婴安全

Key words

ropivacaine/vaginal delivery/epidural labor analgesia, clinical effect,safety of mother and infant

分类

医药卫生

引用本文复制引用

姜国玉,何开华..罗哌卡因复合舒芬太尼硬膜外分娩镇痛效果及安全性分析[J].中国药业,2017,26(24):33-35,3.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文